Veterinary Medicine Information website

Gallivac IB88 Neo

Authorised
  • Infectious bronchitis virus, type 793/B, strain CR88121, Live
Download as PDF

Product identification

Medicine name:
Gallivac IB88 Neo
Active substance:
  • Infectious bronchitis virus, type 793/B, strain CR88121, Live
Target species:
  • Chicken
Route of administration:
  • Topical

Product details

Active substance and strength:
  • Infectious bronchitis virus, type 793/B, strain CR88121, Live
    4.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Topical
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 230a/97-1
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/02/2022
Download